EGFR and glioblastoma: Glioblastomas are also characterized by multiple genetic alterations such as epidermal growth factor receptor (EGFR) amplification, PTEN mutations as well as various signaling pathways including PI3K/AKT/mTOR pathway, Wnt/β-catenin pathway and P53 signaling pathway [2, 3].